BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Pancreatic cancer AND ERBB4, MGC138404, 2066, ENSG00000178568, Q15303, p180erbB4, HER4 AND Treatment
15 results:

  • 1. A Phase 2 Trial of Afatinib in Patients with Solid Tumors that Harbor Genomic Aberrations in the HER family: The MOBILITY3 Basket Study.
    Salawu A; Hansen AR; Spreafico A; Al-Ezzi E; Webster S; Bedard PL; Doi J; Wang L; Siu LL; Abdul Razak AR
    Target Oncol; 2022 May; 17(3):271-281. PubMed ID: 35635640
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Recent Advances in Epidermal Growth Factor Receptor Inhibitors (EGFRIs) and their Role in the treatment of cancer: A Review.
    Unnisa A; Chettupalli AK; Hussain T; Kamal MA
    Anticancer Agents Med Chem; 2022; 22(20):3370-3381. PubMed ID: 35400324
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Synergistic activity of agents targeting growth factor receptors, CDKs and downstream signaling molecules in a panel of pancreatic cancer cell lines and the identification of antagonistic combinations: Implications for future clinical trials in pancreatic cancer.
    Khan T; Seddon AM; Dalgleish AG; Khelwatty S; Ioannou N; Mudan S; Modjtahedi H
    Oncol Rep; 2020 Dec; 44(6):2581-2594. PubMed ID: 33125153
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. The role of erbb4 in cancer.
    Segers VFM; Dugaucquier L; Feyen E; Shakeri H; De Keulenaer GW
    Cell Oncol (Dordr); 2020 Jun; 43(3):335-352. PubMed ID: 32219702
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. erbb4 promotes the proliferation of gastric cancer cells via the PI3K/Akt signaling pathway.
    Xu J; Gong L; Qian Z; Song G; Liu J
    Oncol Rep; 2018 Jun; 39(6):2892-2898. PubMed ID: 29620274
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. miR-551b regulates epithelial-mesenchymal transition and metastasis of gastric cancer by inhibiting erbb4 expression.
    Song G; Zhang H; Chen C; Gong L; Chen B; Zhao S; Shi J; Xu J; Ye Z
    Oncotarget; 2017 Jul; 8(28):45725-45735. PubMed ID: 28501849
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Cervical small cell neuroendocrine tumor mutation profiles via whole exome sequencing.
    Cho SY; Choi M; Ban HJ; Lee CH; Park S; Kim H; Kim YS; Lee YS; Lee JY
    Oncotarget; 2017 Jan; 8(5):8095-8104. PubMed ID: 28042953
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. The prognostic significance of human epidermal growth factor receptor family protein expression in operable pancreatic cancer : HER1-4 protein expression and prognosis in pancreatic cancer.
    Li Q; Zhang L; Li X; Yan H; Yang L; Li Y; Li T; Wang J; Cao B
    BMC Cancer; 2016 Nov; 16(1):910. PubMed ID: 27871278
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. A comprehensive review of the preclinical efficacy profile of the ErbB family blocker afatinib in cancer.
    Modjtahedi H; Cho BC; Michel MC; Solca F
    Naunyn Schmiedebergs Arch Pharmacol; 2014 Jun; 387(6):505-21. PubMed ID: 24643470
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. The ErbB/HER family of protein-tyrosine kinases and cancer.
    Roskoski R
    Pharmacol Res; 2014 Jan; 79():34-74. PubMed ID: 24269963
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Investigational therapies targeting the ErbB (EGFR, HER2, HER3, her4) family in GI cancers.
    Desai MD; Saroya BS; Lockhart AC
    Expert Opin Investig Drugs; 2013 Mar; 22(3):341-56. PubMed ID: 23316969
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Targeting EGFR in pancreatic cancer treatment.
    Troiani T; Martinelli E; Capasso A; Morgillo F; Orditura M; De Vita F; Ciardiello F
    Curr Drug Targets; 2012 Jun; 13(6):802-10. PubMed ID: 22458527
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Mechanisms of resistance to Erbitux (anti-epidermal growth factor receptor) combination therapy in pancreatic adenocarcinoma cells.
    Arnoletti JP; Buchsbaum DJ; Huang ZQ; Hawkins AE; Khazaeli MB; Kraus MH; Vickers SM
    J Gastrointest Surg; 2004 Dec; 8(8):960-9; discussion 969-70. PubMed ID: 15585383
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Preoperative versus postoperative chemoradiation for patients with resected pancreatic adenocarcinoma.
    Pendurthi TK; Hoffman JP; Ross E; Johnson DE; Eisenberg BL
    Am Surg; 1998 Jul; 64(7):686-92. PubMed ID: 9655283
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Effect of octreotide on gastrostomy, duodenostomy, and cholecystostomy effluents: a physiologic study of fluid and electrolyte balance.
    Niv Y; Charash B; Sperber AD; Oren M
    Am J Gastroenterol; 1997 Nov; 92(11):2107-11. PubMed ID: 9362203
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.